Innovative Eyewear Inc. Reports Record Second Quarter 2026 Results

Rhea-AI Summary

Innovative Eyewear (NASDAQ: LUCY) reported record second quarter 2026 net revenue of $1.01 million, up 74% year over year and marking its first quarter above $1 million and twelfth consecutive quarter of revenue growth. Growth was driven mainly by Lucyd Armor smart safety glasses (about 4,700 units, nearly 100% Y/Y) and Reebok smartglasses (over 1,600 units versus about 400).

Gross margin improved to 24% from a (2)% gross loss, aided by tariff mitigation and better sourcing. Q2 operating expenses fell 10% to $1.95 million, reducing net loss to $1.67 million from $2.11 million. For the first half, revenue rose 73% to $1.78 million and net loss was $3.98 million. At June 30, 2026, the company held $3.74 million in cash, equivalents and investments, no debt, and later raised about $4.0 million gross through at-the-market sales and a July warrant inducement, bringing cash and investments to approximately $5.2 million as of August 11, 2026.

Positive

• Q2 2026 net revenue $1.01M, up 74% year over year
• Gross margin improved from (2)% loss to 24% in Q2
• Q2 operating expenses down 10% year over year to $1.95M
• Net loss reduced 21% Y/Y in Q2 to $1.67M
• Unit growth: ~4,700 Lucyd Armor (+~100%) and >1,600 Reebok vs ~400
• Liquidity: $5.2M cash/investments as of Aug 11, 2026, with no debt

Negative

• Q2 2026 net loss $1.67M and H1 2026 net loss $3.98M
• Cash and investments fell from $6.51M (Dec 31, 2025) to $3.74M (Jun 30, 2026)
• Share dilution: weighted average shares 3.21M to 6.41M Y/Y; 8.61M outstanding Aug 11, 2026
• H1 2026 operating expenses increased 5% year over year to $4.49M
• Equity financing reliance: ~$1.41M net ATM proceeds plus ~$2.6M net warrant inducement

News Explained

As of August 11, 2026, 8,609,196 shares were outstanding, making the disclosed equity activity relevant to existing holders’ percentage ownership.

The unaudited results cover the six months ended June 30, 2026; the company also reports 8,609,196 shares outstanding as of August 11, 2026, after six-month at-the-market common-stock sales and a July 9 warrant inducement that closed for gross proceeds.

Because the at-the-market sales were common-stock sales, they add shares; issuing additional shares increases the total share count and reduces an existing holder’s percentage ownership absent offsetting changes.

Separately, the Canadian rollout was underway, with initial shipments to approximately 345 clinics commencing in July, while the 183-store U.S. test is scheduled to begin in October 2026; the first has started and the second remains scheduled.

Market Context

Tag-matched earnings events averaged -4.45% in the platform record. That history adds a volatility b...

Analysis

Tag-matched earnings events averaged -4.45% in the platform record. That history adds a volatility benchmark to this report's revenue and margin gains; the cash decline and share issuance remain risks to monitor.

Key Figures

Net revenue: $1,010,519 Gross profit and margin: $242,515; 24% Operating expenses: $1,947,474 +5 more

8 metrics

Net revenue $1,010,519 Q2 2026; up 74% year over year

Gross profit and margin $242,515; 24% Q2 2026 versus a $12,665 gross loss and (2)% margin

Operating expenses $1,947,474 Q2 2026; down 10% year over year

Net loss and EPS $1,670,818; $(0.26) per share Q2 2026; net loss decreased 21%

Weighted average shares 6.41 million Q2 2026 versus 3.21 million in Q2 2025

Cash and investments $3.74 million June 30, 2026 versus $6.51 million at December 31, 2025

ATM proceeds $1.46 million gross; $1.41 million net Six months ended June 30, 2026

Warrant inducement proceeds $3.0 million gross; $2.6 million net Transaction closed July 9, 2026

Previous Earnings Reports

5 past events · Latest: May 14 (Positive)

Same Type Pattern 5 events

Date	Event	Sentiment	24h Move	Catalyst
May 14	Q1 earnings report	Positive	-7.9%	Revenue growth and margin improvement were followed by a -7.92% 24-hour reaction.
Apr 22	Preliminary Q1 results	Positive	+4.9%	Preliminary sales growth and improving margins preceded a 4.9% 24-hour reaction.
Mar 25	FY2025 earnings report	Positive	+0.0%	Revenue and gross-margin gains were followed by a 0% 24-hour reaction.
Nov 13	Q3 earnings report	Negative	-12.4%	The reported net loss coincided with a -12.43% 24-hour reaction.
Aug 14	Q2 earnings report	Negative	-6.8%	Gross-margin deterioration and a net loss preceded a -6.82% 24-hour reaction.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Tag-matched earnings events averaged a -4.45% move, with positive earnings announcements producing both positive and negative reactions.

Key Terms

gross margin, at-the-market, net working capital, white-label

4 terms

gross margin financial

"Y-O-Y Second Quarter Revenue Increased 74% & Gross Margin Improved to 24%"

Gross margin is the difference between how much money a company makes from selling its products and how much it costs to produce them, expressed as a percentage of sales. It shows how efficiently a company is turning sales into profit before other expenses like marketing or salaries. Higher gross margin means the company keeps more money from each sale, which is a good sign of financial health.

View in glossary

at-the-market financial

"The Company received approximately $1.46 million of gross proceeds from at-the-market sales"

"At-the-market" is a method for companies to sell new shares of stock directly into the open market over time, rather than all at once. It allows companies to raise money gradually, similar to selling slices of a pie instead of the entire pie at once, which can help manage the sale's impact on the stock price. This approach gives investors a steady supply of shares while providing companies with flexible funding options.

net working capital financial

"Net working capital was $6.22 million, compared with $8.39 million"

Net working capital is the amount left when you subtract a company’s short-term bills (like accounts payable and short-term loans) from its short-term assets (cash, money owed to it, and inventory). Think of it as the cash cushion a business has to keep daily operations running — a bigger cushion means fewer short-term funding worries, while a small or negative number can signal pressure to raise cash or cut activity, which matters to investors assessing stability and short-term risk.

white-label technical

"The Company has also launched a white-label offering for retailers"

A white-label product or service is made by one company but sold under another company's brand so the reseller can offer it as if they created it. Think of it like a supermarket selling a generic cereal that was produced in the same factory as national brands. For investors, white-label arrangements can boost revenue and speed market entry with lower development costs, but they also concentrate reliance on third-party suppliers and can limit differentiation and pricing power.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Y-O-Y Second Quarter Revenue Increased 74% & Gross Margin Improved to 24% 

MIAMI, Aug. 14, 2026 /PRNewswire/ -- Innovative Eyewear Inc., (NASDAQ: LUCY, LUCYW), ("Innovative Eyewear" or the "Company") the developer of smart eyewear under the Lucyd®, Lucyd Armor®, Reebok®, Nautica®, and Eddie Bauer® brands, today announced its unaudited financial results for the three and six months ended June 30, 2026.

Harrison Gross, CEO of Innovative Eyewear Inc., commented, "We didn't just carry our first-quarter momentum into the second quarter — we accelerated it, surpassing $1 million in quarterly revenue for the first time in our history while returning gross margin to positive territory. We intend to build on this momentum in the second half, and we remain very optimistic about our outlook for 2026 and beyond."

Net revenue for the three months ended June 30, 2026 (the "current quarter") was $1,010,519, an increase of $431,289 or 74% from the prior year quarter — the twelfth consecutive quarter of year-over-year revenue growth, the first quarter in the Company's history with net revenue above $1 million, and an acceleration from approximately 63% growth for full-year 2025 and 70% in the first quarter of 2026. Growth was predominantly attributable to volume, driven by Lucyd Armor® smart safety glasses, of which approximately 4,700 units were sold, a nearly 100% increase year-over-year, and by cobranded Reebok® sport and optical smartglasses, of which over 1,600 units were sold compared with approximately 400, partially offset by declines in certain other product lines.

Gross profit was $242,515, or 24% of net revenue, compared with a gross loss of $12,665, or (2)%, in the prior year quarter — an improvement of approximately 26 percentage points, reflecting a rebound from tariffs imposed on U.S. imports beginning in April 2025 and management's actions to mitigate them, which have largely restored margins to levels consistent with the Company's pre-tariff business plan.

Total operating expenses were $1,947,474, a decrease of $210,933 or 10%, on a $126,131 decrease in research and development costs and a $92,296 decrease in general and administrative expenses, the latter primarily on lower legal and outside consultant expenses, partially offset by higher public relations and branding spending and higher license royalties. Other non-operating income was approximately $34,141, compared with $64,978. Net loss was $1,670,818 or $(0.26) per share, basic and diluted, compared with $2,106,094 or $(0.66) per share — a 21% reduction. Weighted average shares outstanding for the three months ended June 30, 2026 and 2025 were approximately 6.41 million and 3.21 million, respectively.

Net revenue for the six months ended June 30, 2026 was $1,784,080, an increase of $750,349 or 73%, driven primarily by volume — approximately 8,800 Lucyd Armor® units, a 91% increase, and nearly 2,000 Reebok® units — with the remainder largely driven by favorable price/mix from 2026 Lucyd Armor® price increases and the April 2026 Reebok® optical launch at premium price points, partially offset by a higher proportion of wholesale sales at wholesale pricing. Gross profit margin was 23%, compared with 20% in the prior year period, which, as previously disclosed, included approximately $132,000 of one-off credits and inventory adjustments not representative of run-rate margin. The improvement primarily reflects better sourcing costs for frames and prescription lenses as order volumes have grown, together with tariff mitigation.

Total operating expenses for the six months were $4,494,684, an increase of $211,953 or 5%, driven by a $406,407 increase in general and administrative expenses — compensation and benefits, public relations and branding, and license royalties — partially offset by significant decreases in research and development costs. Other non-operating income was approximately $96,538, compared with $190,066. Net loss was $3,980,186 or $(0.63) per share, basic and diluted, compared with $3,884,797 or $(1.37) per share. Weighted average shares outstanding for the six months ended June 30, 2026 and 2025 were approximately 6.33 million and 2.84 million, respectively.

At June 30, 2026 the Company held approximately $3.74 million of combined cash and cash equivalents and investments, compared with $6.51 million at December 31, 2025. Net working capital was $6.22 million, compared with $8.39 million, with no outstanding debt and long-term liabilities of only approximately $0.01 million. During the six months the Company received approximately $1.46 million of gross proceeds, or $1.41 million net, from at-the-market sales of common stock. Subsequent to quarter end, on July 9, 2026, the Company closed a warrant inducement transaction generating approximately $3.0 million of gross proceeds, or $2.6 million net, intended for working capital and general corporate purposes.^[1] 

As of August 11, 2026, the Company had approximately $5.2 million of combined cash and cash equivalents and investments, and 8,609,196 shares of common stock issued and outstanding.

The Company expects to sustain this revenue growth momentum, supported by several commercial initiatives now underway:

• Premium product momentum. In April 2026 the Company launched the new Reebok® Powered by Lucyd optical collection, its highest average selling price frame collection to date.

• Canadian retail rollout underway. As previously announced in July 2026, the Company entered into a retail launch with FYihealth group, operators of the FYidoctors optical chain in Canada, centered on the 2026 rollout of Lucyd Armor® in approximately 345 FYidoctors and Visique clinics. Initial shipments commenced in July 2026.

• Expanding U.S. retail footprint. The Company has been selected for a wearables brand test with a major U.S. and global retailer covering 183 stores, with the in-store set scheduled to begin in October 2026. Together with these partnerships, the Company expects the number of retail locations offering its products to increase materially during 2026 from over 400 at the end of 2025.

• Enterprise demand and a new white-label channel. Several leading industrial and logistics companies are testing Lucyd Armor® for workforce use. The Company has also launched a white-label offering for retailers and legacy eyewear brands, and is in advanced discussions with a prospective customer for a white-label line of smart safety glasses.

______________________________

1 The Company advanced $250,000 to Tekcapital Europe, Ltd., a subsidiary of Tekcapital plc, under a short-term note bearing simple interest at 12% per annum, guaranteed by Tekcapital plc.

About Innovative Eyewear, Inc.

Innovative Eyewear is a developer of cutting-edge ChatGPT- and Claude-enabled smart eyewear, under the Lucyd®, Lucyd Armor®, Reebok®, Nautica®, and Eddie Bauer® brands. True to our mission to Upgrade Your Eyewear®, our Bluetooth smart glasses allow users to stay safely and ergonomically connected to their digital lives and are offered in hundreds of frame and lens combinations to meet the needs of the optical market. To learn more and explore our continuously evolving collection of smart eyewear, please visit www.lucyd.co. 

Forward-Looking Statements

This press release contains certain forward-looking statements, including those relating to the Company's business operations, projections, market position, revenue growth, liquidity, commercial discussions, pipeline opportunities, prospective customers and channel partners, anticipated product launches and retail listings, and future product lines and developments. Forward-looking statements are based on the Company's current expectations and assumptions. The Private Securities Litigation Reform Act of 1995 provides a safe-harbor for forward-looking statements. These statements may be identified by the use of forward-looking expressions, including, but not limited to, "anticipate," "believe," "continue," "estimate," "expect," "future," "intend," "may," "outlook," "plan," "potential," "predict," "project," "should," "will," "would" and similar expressions that predict or indicate future events or trends or that are not statements of historical matters, but the absence of these words does not mean that a statement is not forward-looking. The retail test, partnerships and commercial discussions described in this release have not resulted in definitive agreements except as expressly stated, and there can be no assurance that any such discussions will result in executed agreements or generate revenue on the timing or in the volumes described, or at all. The Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Important factors that could cause actual results to differ materially from those in the forward-looking statements are set forth in the Company's filings with the Securities and Exchange Commission, including its annual report on Form 10-K under the caption "Risk Factors" and its quarterly report on Form 10-Q for the quarterly period ended June 30, 2026.

Investor Relations Contact:

Scott Powell
Skyline Corporate Communications Group, LLC
Telephone: +1 (646) 893-5835
Email: IR@skylineccg.com

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/innovative-eyewear-inc-reports-record-second-quarter-2026-results-302851966.html

SOURCE Innovative Eyewear, Inc.

FAQ

How did Innovative Eyewear (NASDAQ: LUCY) perform in Q2 2026?

Innovative Eyewear reported Q2 2026 net revenue of $1,010,519, up 74% year over year, and its first-ever quarter above $1 million. According to the company, this was its twelfth consecutive quarter of year-over-year revenue growth, driven mainly by Lucyd Armor and Reebok smart eyewear volume.

What was Innovative Eyewear (LUCY) net loss and EPS in Q2 2026?

Innovative Eyewear recorded a Q2 2026 net loss of $1,670,818, or $(0.26) per share basic and diluted. According to the company, this compares with a $2,106,094 net loss, or $(0.66) per share, in the prior-year quarter, reflecting a 21% reduction in net loss.

How did gross margin change for Innovative Eyewear (LUCY) in Q2 2026?

Gross margin improved to 24% of net revenue in Q2 2026, versus a (2)% gross loss a year earlier. According to Innovative Eyewear, this approximately 26-point improvement reflects tariff mitigation and better sourcing costs, largely restoring margins to its pre-tariff business plan levels.

What is Innovative Eyewear (LUCY) revenue growth for the first half of 2026?

For the six months ended June 30, 2026, net revenue was $1,784,080, a 73% year-over-year increase. According to the company, growth was driven mainly by a 91% increase in Lucyd Armor units, nearly 2,000 Reebok units sold, and favorable price mix from new premium products.

What is Innovative Eyewear (LUCY) cash position and debt as of mid-2026?

At June 30, 2026, Innovative Eyewear had about $3.74 million in cash, cash equivalents and investments, with no outstanding debt and minimal long-term liabilities. According to the company, subsequent financings raised additional cash, bringing this balance to approximately $5.2 million by August 11, 2026.

How is Innovative Eyewear (LUCY) funding growth in 2026 and what about dilution?

Innovative Eyewear raised roughly $1.41 million net through at-the-market share sales and about $2.6 million net via a July 2026 warrant inducement. According to the company, weighted average shares rose to 6.33 million for H1 2026, with 8,609,196 shares outstanding as of August 11, 2026.

What growth initiatives is Innovative Eyewear (LUCY) pursuing for 2026?

Innovative Eyewear expects to sustain revenue momentum via premium Reebok optical launches, a Canadian rollout with FYidoctors and Visique, a U.S. wearables test in 183 stores, and enterprise and white-label channels. According to the company, these initiatives should materially expand its retail location count during 2026.